Max Neeman International and AMEDON Collaborate to Increase EDC Performance
Max Neeman International offers additional electronic data management system in collaboration with German software company, AMEDON GmbH for enhanced and expanded Electronic Data Capture (EDC) services.
RESEARCH TRIANGLE PARK, N.C., March 4 /PRNewswire/ -- Max Neeman International, a leading Indian CRO, adds to its Data Management and EDC services offering an alternative on the systematic data acquisition and data storage in a secure database for processing. The company already designs and implements a Clinical Data Management System (CDMS) using SAS PheedIt, a web based system used for paper based as well as EDC trials, with positive results. AMEDON's focus is electronic data capture software for the EDC trials only. All the procedures for both systems are compliant to FDA 21 CFR Part 11 and industry guidelines.
The AMEDON electronic data capture tool has certain unique features like: easy data entry/data capture at the site end, serious adverse event reporting alerts and direct capture of laboratory inputs.
Main features of the products:
- Decentralized data acquisition and centralized data collection via Internet - for reports to be created in a controlled way and activities to be performed in a timely manner.
- With the use of Max Neeman's standardized open Internet technologies, no specialized software is required.
- The Max Neeman comprehensive security concept ensures that even the strictest regulatory requirements are reliably met.
Max Neeman offers a complete Data Management & Biostatistical solution to the clinical research/pharmaceutical industry. The approach is to fulfill client requirements, deliver Data Management & Biostatistical solutions which are regulatory–compliant, secure and cost-effective. Max Neeman's Data Management team handles trials across 60 countries.
About AMEDON GmbH
AMEDON specializes in developing, producing, and marketing web-based solutions for data acquisition, data presentation, and data analysis in clinical research and medical applications.
About Max Neeman International
Max Neeman International is one of the leading and largest CROs in India. We offer services for the successful conduct of Phase I-IV clinical and device trials for small and mid-sized international and national Pharmaceutical, Biotechnology, Medical Device and Nutraceutical companies in compliance with ICH GCP standards. Operational since 2001, Max Neeman is an ISO 9001:2000 certified CRO for Monitoring, Site Management and Data Management Services. The company is presently active in 22 cities with 5 regional offices. Please contact Donald Swankie, Vice President for more information (email@example.com +1.919.424.3345). http://www.neeman-medical.com
SOURCE Max Neeman International
More by this Source
Regulatory Update on India Clinical Research Approval Timelines
Feb 03, 2014, 12:11 ET
Dr. Renu Razdan of Max Neeman International Appointed Vice Chairman, ACRO India
Dec 05, 2013, 11:47 ET
Dr. Renu Razdan of Max Neeman International Speaks at Lilly Women India Network Event
Oct 14, 2013, 11:33 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.